HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SDX 308

a nonsteroidal anti-inflammatory agent that inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth; structure in first source
Also Known As:
CEP 18082; CEP-18082; CEP18082; SDX-308; SDX308
Networked: 6 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Lentzsch, Suzanne: 3 articles (10/2007 - 03/2007)
2. Elliott, Gary: 3 articles (10/2007 - 03/2007)
3. Roodman, G David: 2 articles (10/2007 - 03/2007)
4. Feng, Rentian: 2 articles (09/2007 - 03/2007)
5. Leoni, Lorenzo: 2 articles (08/2007 - 03/2007)
6. Smolewski, Piotr: 1 article (08/2008)
7. Robak, Tadeusz: 1 article (08/2008)
8. Robak, Pawel: 1 article (08/2008)
9. Larsson, Rolf: 1 article (08/2007)
10. Lindhagen, Elin: 1 article (08/2007)

Related Diseases

1. Multiple Myeloma
2. Neoplasms (Cancer)
3. B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
4. Osteoporosis
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Etodolac (Lodine)
2. Melphalan (Alkeran)
3. Dexamethasone (Maxidex)
4. bortezomib (Velcade)
5. I-kappa B Kinase
6. beta Catenin
7. NF-kappa B (NF-kB)
8. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
9. NF-kappaB inhibitor alpha
10. antineoplaston A10 (A 10)